Balancing Patient Autonomy and Medical Responsibility in Steroid Dependency Management: Ethical Dilemmas, Clinical Realities, and Practical Pathways
Steroid dependency, most commonly involving long-term systemic glucocorticoids, sits at a difficult intersection of symptom relief, physiologic adaptation (HPA-axis suppression), psychological reliance, and iatrogenic harm. Clinicians routinely face ethically charged decisions when patients strongly prefer continued or higher-dose steroids despite clear risks (infection, osteoporosis, metabolic disease, psychiatric effects, adrenal crisis, etc.). This review synthesizes core ethical principles (autonomy, beneficence, non-maleficence, justice), contemporary models of shared decision-making, and bedside strategies for navigating conflict while maintaining patient dignity and safety. We distinguish autonomy from unbounded choice, outline how capacity and voluntariness can be compromised by steroidinduced mood/cognition changes and fear of relapse, and show how “medical responsibility” is best framed as harm prevention + partnership, not paternalism. We propose a practical ethical-clinical workflow: clarify indication and goals, assess dependency drivers (physiologic vs psychological vs disease-driven), quantify risk, evaluate decisionmaking capacity, communicate options with uncertainty transparently, agree on a harm-minimizing plan (including tapering/bridging), and document shared decisions. Special attention is given to high-risk scenarios (refusal to taper, clandestine steroid use, comorbid mental illness, pregnancy, adolescents, chronic inflammatory disease, and lowresource settings). The review concludes with a set of “ethical red flags,” a negotiation toolkit, and system-level recommendations (protocols, multidisciplinary clinics, deprescribing pathways) that protect both patients and clinicians.